A CIMT test (carotid intima-media thickness test) is a painless ultrasound exam that measures the thickness of the inner two layers of your carotid arteries, the large blood vessels on each side of your neck that supply blood to your brain. The measurement, taken in fractions of a millimeter, reveals early signs of atherosclerosis (plaque buildup in artery walls) before it causes symptoms or shows up on other tests. The exam takes about 30 to 45 minutes, involves no radiation or needles, and gives your doctor a direct look at the structural health of your arteries.
What the Test Actually Measures
Your artery walls have three layers. From the inside out: the intima (the smooth inner lining that contacts your blood), the media (a muscular middle layer), and the adventitia (the tough outer shell). A CIMT test measures the combined thickness of the first two layers, the intima and the media, using high-frequency ultrasound. On the screen, these layers appear as two bright parallel lines with a darker space between them. The distance between those lines is your CIMT measurement.
This matters because atherosclerosis begins in the intima. Cholesterol, inflammatory cells, and other debris infiltrate that inner layer and cause it to thicken long before you’d ever notice a problem. By the time symptoms appear (chest pain, shortness of breath, or stroke), the disease is often advanced. CIMT captures this process in its earliest stages, sometimes decades before a cardiac event.
How CIMT Predicts Heart Disease Risk
A single CIMT measurement is associated with future cardiovascular events, including heart attacks, strokes, and procedures like bypass surgery or stenting, even after accounting for standard risk factors like cholesterol, blood pressure, and smoking. But the test becomes especially powerful when repeated over time. A large meta-analysis of 119 clinical trials involving over 100,000 patients found that for every 10 micrometers per year that artery wall thickening slowed down, the risk of a major cardiovascular event dropped by about 9%. People whose treatment slowed thickening by 30 to 40 micrometers per year saw their risk fall by roughly 30% to 37%.
In other words, the rate of change in your artery wall thickness directly tracks with your actual risk of having a heart attack or stroke. This makes repeat CIMT testing useful for monitoring whether lifestyle changes or medications are working at the level of your artery walls, not just on a lab report.
How It Compares to a Calcium Score
A coronary artery calcium (CAC) score, sometimes called a heart scan, uses a CT scanner to detect hardened calcium deposits in your coronary arteries. It’s a well-established screening tool, but it measures a later stage of disease. Calcium appears in plaque only after it has been building for years. For younger or middle-aged adults whose plaque hasn’t calcified yet, a calcium score of zero can be falsely reassuring. Research published in Mayo Clinic Proceedings found that CIMT is more sensitive than calcium scoring at detecting subclinical atherosclerosis in younger populations, precisely the group that would benefit most from early intervention.
The two tests also differ practically. A calcium score requires a CT scanner and a small dose of radiation. CIMT uses only ultrasound, with no radiation exposure at all. That said, the correlation between the two tests is weak because they’re measuring different things: CIMT captures early arterial wall changes while calcium scoring identifies more advanced calcified plaque. They’re complementary rather than interchangeable.
Who Benefits Most From the Test
CIMT is most useful for people in the gray zone of cardiovascular risk. Standard risk calculators estimate your 10-year chance of a heart attack or stroke based on age, cholesterol, blood pressure, diabetes status, and smoking. If your risk clearly falls in the low or very high category, the next steps are straightforward. But many people land in the borderline (5% to under 7.5%) or intermediate (7.5% to under 20%) range, where the decision about whether to start preventive treatment like a statin is less clear.
For these patients, CIMT can tip the balance. If your artery walls are thicker than expected for your age and sex, that’s evidence of subclinical disease that standard blood tests miss. It can also be valuable for people with a strong family history of early heart disease, those with metabolic conditions like diabetes or insulin resistance, or anyone whose traditional risk factors don’t seem to match their actual cardiovascular trajectory. Japan’s Atherosclerosis Society actively recommends considering CIMT for assessing subclinical atherosclerosis. However, the American Heart Association, American College of Cardiology, and European Society of Cardiology currently do not recommend it for routine screening, citing a lack of standardized measurement protocols and limited additional predictive value beyond traditional risk factors and calcium scoring.
What to Expect During the Exam
The procedure is essentially an ultrasound of your neck. You lie on your back on an exam table, and a technician applies a thin layer of gel to both sides of your neck. They then press a small handheld device (a transducer) gently against your skin and slowly move it along the path of each carotid artery. The transducer sends out sound waves and captures their reflections, building a real-time image of your artery walls on a monitor.
There’s no special preparation required. You don’t need to fast, stop medications, or avoid caffeine. The only practical tip: wear a shirt with a loose or open collar, since the technician needs easy access to both sides of your neck. The whole exam takes 30 to 45 minutes, and you can return to normal activities immediately.
Understanding Your Results
Your results will include a CIMT measurement in millimeters, typically compared against reference values for your age and sex. The widely used Mannheim Consensus criteria define a normal measurement as anything below 1.5 mm. A reading of 1.5 mm or above is considered thickened and may indicate the presence of plaque.
Most clinicians compare your result to a percentile chart. A measurement above the 75th percentile for your age group suggests your arteries are aging faster than expected and that you may have a higher cardiovascular risk than standard calculators predict. A reading below the 25th percentile is generally reassuring. Results in the middle range are interpreted alongside your other risk factors. The most informative use of CIMT involves tracking your measurement over time. A stable or decreasing value suggests your prevention strategy is working. A rising value is a signal to reassess.
Advantages and Limitations
The biggest advantages of CIMT are safety and accessibility. It uses no radiation, no contrast dye, and no needles. It’s noninvasive, painless, and relatively inexpensive. For patients covered by Medicare, the out-of-pocket cost averages around $100 to $135 depending on the facility. Private insurance coverage varies, and some plans may not cover it for asymptomatic screening.
The main limitation is operator dependence. Unlike a calcium score, which a computer calculates from a CT scan, CIMT relies heavily on the technician’s skill in positioning the transducer and capturing the right images, and on the reader’s precision in measuring the wall thickness. Small differences in technique can lead to meaningful differences in the number reported. This variability is one reason major cardiology guidelines have hesitated to endorse CIMT for routine use. If you’re getting the test, it’s worth seeking a facility that performs CIMT regularly and uses automated measurement software, which reduces human error. Repeating the test at the same facility with the same protocol also makes year-to-year comparisons more reliable.